Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

CLPT

ClearPoint Neuro (CLPT)

ClearPoint Neuro Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:CLPT
FechaHoraFuenteTítuloSímboloCompañía
17/10/202415:05GlobeNewswire Inc.ClearPoint Neuro to Announce Third Quarter 2024 Results November 7, 2024NASDAQ:CLPTClearPoint Neuro Inc
11/10/202416:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CLPTClearPoint Neuro Inc
26/08/202415:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CLPTClearPoint Neuro Inc
26/08/202415:05GlobeNewswire Inc.ClearPoint Neuro Announces Early Repayment of $10 Million NoteNASDAQ:CLPTClearPoint Neuro Inc
07/08/202416:16Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CLPTClearPoint Neuro Inc
07/08/202415:05GlobeNewswire Inc.ClearPoint Neuro Reports Second Quarter 2024 ResultsNASDAQ:CLPTClearPoint Neuro Inc
17/07/202415:05GlobeNewswire Inc.ClearPoint Neuro to Announce Second Quarter 2024 Results August 7, 2024NASDAQ:CLPTClearPoint Neuro Inc
20/06/202407:45GlobeNewswire Inc.ClearPoint Neuro Congratulates Partner Aspen Neuroscience on Use of the ClearPoint® Navigation System for All Enrolled Patients in ASPIRO Clinical TrialNASDAQ:CLPTClearPoint Neuro Inc
20/06/202407:30PR Newswire (US)Parkinson's Disease Clinical Trial Uses Intraoperative MRI to Guide Precision Implantation of Patients' Own Autologous Replacement NeuronsNASDAQ:CLPTClearPoint Neuro Inc
01/06/202408:00GlobeNewswire Inc.ClearPoint Neuro Announces Full Market Release of SmartFrame OR™ and ClearPoint PRISM® 3T Laser Therapy SystemNASDAQ:CLPTClearPoint Neuro Inc
16/05/202415:18Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:CLPTClearPoint Neuro Inc
07/05/202415:05GlobeNewswire Inc.ClearPoint Neuro Reports First Quarter 2024 ResultsNASDAQ:CLPTClearPoint Neuro Inc
02/05/202415:05GlobeNewswire Inc.ClearPoint Neuro to Present Novel Research and Exhibit at the 27th American Society of Gene & Cell Therapy Annual Meeting in BaltimoreNASDAQ:CLPTClearPoint Neuro Inc
29/04/202407:00GlobeNewswire Inc.ClearPoint Neuro Announces FDA Clearance of Prism Bone Anchor AccessoryNASDAQ:CLPTClearPoint Neuro Inc
24/04/202415:05GlobeNewswire Inc.ClearPoint Neuro Announces Initiation of Limited Market Release for the SmartFrame OR™ Stereotactic SystemNASDAQ:CLPTClearPoint Neuro Inc
23/04/202415:05GlobeNewswire Inc.ClearPoint Neuro to Announce First Quarter 2024 Results May 7, 2024NASDAQ:CLPTClearPoint Neuro Inc
16/04/202415:05GlobeNewswire Inc.ClearPoint Neuro Congratulates its Partner AviadoBio on First Patient Treated in its ASPIRE-FTD Clinical Trial Evaluating AVB-101 for Frontotemporal Dementia with GRN MutationsNASDAQ:CLPTClearPoint Neuro Inc
19/03/202407:07GlobeNewswire Inc.ClearPoint Neuro Congratulates its Partner PTC Therapeutics on Completion of Biologics License Application Submission to FDA for Upstaza™ as a Treatment for AADC DeficiencyNASDAQ:CLPTClearPoint Neuro Inc
12/03/202415:05GlobeNewswire Inc.ClearPoint Neuro Reports Fourth Quarter and Full-Year 2023 ResultsNASDAQ:CLPTClearPoint Neuro Inc
11/03/202407:00GlobeNewswire Inc.Journal of Neurosurgery Publication Demonstrates Distinct Advantages of ClearPoint Prism® Neuro Laser Therapy SystemNASDAQ:CLPTClearPoint Neuro Inc
01/03/202415:05GlobeNewswire Inc.ClearPoint Neuro to Announce Fourth Quarter and Full Year 2023 Results March 12, 2024NASDAQ:CLPTClearPoint Neuro Inc
01/03/202407:00Edgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NASDAQ:CLPTClearPoint Neuro Inc
29/02/202407:00GlobeNewswire Inc.ClearPoint Neuro Announces Pricing of Public Offering of 2,307,694 Shares of Common StockNASDAQ:CLPTClearPoint Neuro Inc
28/02/202415:45GlobeNewswire Inc.ClearPoint Neuro Launches Proposed Public Offering of Common StockNASDAQ:CLPTClearPoint Neuro Inc
21/02/202415:05GlobeNewswire Inc.ClearPoint Neuro Announces FDA Clearance and First-in-Human Cases Performed with the New 2.2 Software Version and the Integrated Maestro Brain ModelNASDAQ:CLPTClearPoint Neuro Inc
06/02/202415:30Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CLPTClearPoint Neuro Inc
24/01/202415:05GlobeNewswire Inc.ClearPoint Neuro Announces Installation and First Procedure Using the ClearPoint Prism® Neuro Laser Therapy System and Navigation System at Kaleida Health in BuffaloNASDAQ:CLPTClearPoint Neuro Inc
22/01/202415:05GlobeNewswire Inc.ClearPoint Neuro Announces First EU MDR Certification Success and Approval to Ship Product to EuropeNASDAQ:CLPTClearPoint Neuro Inc
16/01/202407:00GlobeNewswire Inc.ClearPoint Neuro Announces FDA Clearance for SmartFrame OR™ Stereotactic SystemNASDAQ:CLPTClearPoint Neuro Inc
08/01/202415:05GlobeNewswire Inc.ClearPoint Neuro Reports Fourth Quarter and Full Year 2023 Preliminary Revenue Results and Guidance for Full Year 2024 RevenueNASDAQ:CLPTClearPoint Neuro Inc
 Showing the most relevant articles for your search:NASDAQ:CLPT